Document and Entity Information
Document and Entity Information | Jan. 06, 2022 |
Cover [Abstract] | |
Entity Registrant Name | AMEDISYS INC |
Amendment Flag | true |
Entity Central Index Key | 0000896262 |
Document Type | 8-K/A |
Document Period End Date | Jan. 6, 2022 |
Entity File Number | 0-24260 |
Entity Incorporation State Country Code | DE |
Entity Tax Identification Number | 11-3131700 |
Entity Address, Address Line One | 3854 American Way |
Entity Address, Address Line Two | Suite A |
Entity Address, City or Town | Baton Rouge |
Entity Address, State or Province | LA |
Entity Address, Postal Zip Code | 70816 |
City Area Code | (225) |
Local Phone Number | 292-2031 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.001 per share |
Trading Symbol | AMED |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Amendment Description | This Amendment No. 1 to Current Report on Form 8-K (this “Amendment”) amends and supplements the Current Report on Form 8-K (the “Original Form 8-K”) filed by Amedisys, Inc. (the “Company”) with the Commission on January 10, 2022. The Original Form 8-K reported, among other things, the appointment of Christopher T. Gerard as Chief Executive Officer of the Company, effective April 15, 2022. This Amendment is being filed solely to provide information about the compensatory arrangements entered into in connection with the appointment of Mr. Gerard as Chief Executive Officer. |